9/16/2022Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay (The B...

9/16/2022Biotech May Be the Next U.S.-China Battleground (WSJ)

9/15/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...

9/14/2022CDE Issues the List of Reference Formulations for GQCE Studies (58th B...

9/14/2022MIIT: China to Further Optimize Industrial Chain for Pharmaceutical Se...

9/14/2022China Pushes for Mutual Recognition of Drug Regulations at SCO Forum

9/14/2022Antengene Opens New Office in Australia as It Takes On Four Trials in ...

9/14/2022Henlius to Spearhead Global Plans through Partnerships in Emerging Mar...

9/12/2022WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility t...

9/12/2022HitGen's Vernalis Research and Unison Medicines Enter Research Partne...

9/12/2022Cellusion and Fosun's Celregen Enter License Pact over CLS001 for a Co...

9/12/2022CFIUS Derails Asymchem's Acquisition of Snapdragon

9/12/2022Biden Signs Executive Order to Boost US Biotechnology and Cut Relian...

9/9/2022CDE Solicits Comments on Draft Technical Guidelines for Continuous Man...

9/9/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines Q3D(...

9/9/2022Recent Executive Moves

9/7/2022Neovii and Fosun Enter into an Licesing Pact for Grafalon in Greater C...

9/7/2022Vision Forward Remains Blurry for Chinese Economy and Healthcare Secto...

9/7/2022In China, Real-World Evidence Is Playing An Increasingly Important Rol...

9/6/2022China's Veteran Drugmakers Are Rushing into the Nucleic Acid Drug Race...

9/6/2022'Still The Place To Do Drug Innovation': China Biotech CEO Podcast Wit...

9/6/2022A Share-Listed Chinese Pharma Cos Report Performance in H1/2022

9/6/2022KPMG Sued for $830M over Botched Audit of US-Listed China Medical Tech...

9/6/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

9/6/2022NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...

9/5/2022CDE Solicits Comments on Draft Technical Guidelines for Abuse Preventi...

9/5/2022AZ's Forxiga Wins Approval in China for Kidney Disease with/without Ty...

9/5/2022Asieris Acquires Rights to Heart Failure Therapy from Acorda

9/5/2022CellOrigin Enter Strategic Global Collaboration with Qilu Pharma to D...

9/5/2022Debt-Strapped Fosun Intl to Pare Stakes in Listed Subsidiaries Includi...

Page:72/719 Total number of articles:21546: [First][<<] [70] [71] [72] [73] [74] [>>] [End]